Eprosartan

Chemical formula: C₂₃H₂₄N₂O₄S  Molecular mass: 424.513 g/mol  PubChem compound: 5281037

Therapeutic indications

Eprosartan is indicated for:

Essential hypertension

Population group: only adults (18 years old or older)

Eprosartan is indicated for the treatment of essential hypertension.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Eprosartan is contraindicated in the following cases:

Severe hepatic impairment

Hepatic failure stage IV

Pregnancy

Pregnancy

Bilateral renovascular disease, severe stenosis of a single functioning kidney

at least one of
Renovascular hypertension
RAS - Renal artery stenosis

Aliskiren and diabetes mellitus or renal impairment (GFR <60 ml/min/1.73m²)

Aliskiren and additionally at least one of
Diabetes mellitus



Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2018: EPROSARTAN Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈